NMG-438

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameNMG-438
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionLeukocyte-associated immunoglobulin-like receptor 1 antagonists
TargetsLeukocyte-associated immunoglobulin-like receptor 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNGM Biopharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesNGM Biopharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A